Get the app
public
ios_share
Mendelspod Podcast
chevron_right
Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials
Nov 13, 2014
27:35
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
Guest:
Janet, Woodcock, MD, Director, CDER, FDA
Bio and Contact Info
Listen (4:41)
No agency charged with better translational outcomes
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit
www.mendelspod.com/subscribe